Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol

IMPORTANCE: Human papillomavirus (HPV), particularly HPV type 16, causes most anal and vulvar high-grade squamous intraepithelial lesions (HSIL), which are precursors to cancer. After initial treatment of HSIL, more than 30% of patients will have disease recurrence, with even higher recurrence among...

Descripción completa

Detalles Bibliográficos
Autores principales: Stankiewicz Karita, Helen C., Hauge, Kirsten, Magaret, Amalia, Mao, Constance, Schouten, Jeffrey, Grieco, Verena, Xi, Long Fu, Galloway, Denise A., Madeleine, Margaret M., Wald, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481452/
https://www.ncbi.nlm.nih.gov/pubmed/30977845
http://dx.doi.org/10.1001/jamanetworkopen.2019.0819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481452/
https://www.ncbi.nlm.nih.gov/pubmed/30977845
http://dx.doi.org/10.1001/jamanetworkopen.2019.0819

Ejemplares similares